(CUE) Cue Biopharma complete technical analysis [charts+indicators] | Buy/Sell Cue Biopharma | (CUE) share price targets
Complete technical analysis of Cue Biopharma (CUE) by charts plus indicators, forecast predictions and share price targets for Cue Biopharma (CUE)
Cue Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-14 View latest technical analysis
10 day averaged volume of Cue Biopharma is 178170
| Date | Daily Closing Price | Open | High | Low | Volume |
| 14 Fri Feb 2025 | 1.49 | 1.45 | 1.50 | 1.40 | 1.028 times |
| 13 Thu Feb 2025 | 1.42 | 1.34 | 1.43 | 1.28 | 0.97 times |
| 12 Wed Feb 2025 | 1.33 | 1.26 | 1.38 | 1.25 | 1.087 times |
| 11 Tue Feb 2025 | 1.27 | 1.28 | 1.30 | 1.22 | 0.826 times |
| 10 Mon Feb 2025 | 1.33 | 1.25 | 1.34 | 1.25 | 0.688 times |
| 07 Fri Feb 2025 | 1.28 | 1.32 | 1.38 | 1.20 | 2.133 times |
| 06 Thu Feb 2025 | 1.35 | 1.41 | 1.45 | 1.32 | 1.072 times |
| 05 Wed Feb 2025 | 1.42 | 1.42 | 1.50 | 1.38 | 1.2 times |
| 04 Tue Feb 2025 | 1.41 | 1.42 | 1.49 | 1.41 | 0.638 times |
| 03 Mon Feb 2025 | 1.41 | 1.41 | 1.45 | 1.38 | 0.373 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 1.4, but if it comes below 1.4, then a intra day sell could be more profitable.
If you take a sell trade below 1.4, then use 1.4 as stoploss and 1.36 as target. However if you take a buy trade in stock , then use 1.4 as stoploss and 1.5 as target.
Share price targets for Cue Biopharma (CUE)
| Target Type | Value |
| Downside Target | 0.68 |
| Downside Target | 0.92 |
| Downside Target | 1.01 |
| Downside Target | 1.11 |
| Downside Target | 1.20 |
| Downside Target | 1.27 |
| Downside Target | 1.32 |
| Downside Target | 1.49 |
| Upside Target | 1.50 |
| Upside Target | 1.75 |
| Upside Target | 1.95 |
| Upside Target | 1.99 |
Intraday share price targets for Cue Biopharma (CUE)
| Target Type | Value |
| Downside Intraday Target | 1.31 |
| Downside Intraday Target | 1.12 |
| Upside Intraday Target | 1.59 |
| Upside Intraday Target | 1.68 |
| Downside Intraday Target | 1.4 |
Weekly technical analysis of Cue Biopharma (CUE)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 14 Fri Feb 2025 | 1.49 | 1.25 | 1.50 | 1.22 | 0.849 times |
| 07 Fri Feb 2025 | 1.28 | 1.41 | 1.50 | 1.20 | 0.712 times |
| 31 Fri Jan 2025 | 1.45 | 1.42 | 1.50 | 1.27 | 0.779 times |
| 24 Fri Jan 2025 | 1.49 | 1.33 | 1.49 | 1.11 | 8.625 times |
| 17 Fri Jan 2025 | 1.31 | 1.30 | 1.32 | 1.22 | 0.132 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Cue Biopharma (CUE)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 14 Fri Feb 2025 | 1.49 | 1.41 | 1.50 | 1.20 | 0.209 times |
| 31 Fri Jan 2025 | 1.45 | 1.09 | 1.75 | 1.03 | 1.66 times |
| 31 Tue Dec 2024 | 1.09 | 1.11 | 1.23 | 0.92 | 0.395 times |
| 26 Tue Nov 2024 | 1.09 | 1.65 | 1.99 | 1.01 | 0.495 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Cue Biopharma (CUE)
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Cue Biopharma ( (CUE) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Cue Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Cue Biopharma in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Cue Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Cue Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Cue Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.36 and Cue Biopharma (CUE) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Cue Biopharma (CUE) stock. Volume based technical analysis of Cue Biopharma (CUE) stock is negative.
Cue Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Cue Biopharma ( (CUE) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Cue Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Cue Biopharma in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Cue Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Cue Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Cue Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.36 and Cue Biopharma (CUE) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Cue Biopharma (CUE) stock. Volume based technical analysis of Cue Biopharma (CUE) stock is negative.
Cue Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.